Intramuscular vs intravenous oxytocin for active management of the third stage of labor

MOspace/Manakin Repository

Breadcrumbs Navigation

Intramuscular vs intravenous oxytocin for active management of the third stage of labor

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/12346

[-] show simple item record

dc.contributor.author Dresang, Lee T. en_US
dc.date.accessioned 2011-12-19T17:16:41Z
dc.date.available 2011-12-19T17:16:41Z
dc.date.issued 2011-12
dc.identifier.citation Evidence Based Practice 14(12): 12. en_US
dc.identifier.uri http://hdl.handle.net/10355/12346
dc.description.abstract There are no RCTs or other quality evidence to recommend either intramuscular (IM) or intravenous (IV) oxytocin over the other for management of the third stage of labor. Professional bodies recommend both routes of administration equally. en_US
dc.language.iso en_US en_US
dc.publisher Family Physicians Inquiries Network en_US
dc.relation.ispartof Evidence Based Practice 14(12): 12. en_US
dc.subject uterotonic agent en_US
dc.subject.lcsh Childbirth en_US
dc.title Intramuscular vs intravenous oxytocin for active management of the third stage of labor en_US
dc.type Article en_US
dc.relation.ispartofcommunity University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. Evidence Based Practice. en_US
dc.relation.ispartofcollection Evidence Based Practice, 2011 en_US


This item appears in the following Collection(s)

[-] show simple item record